NO831390L - Fremgangsmaate for fremstilling av imidazopyridinderivater - Google Patents

Fremgangsmaate for fremstilling av imidazopyridinderivater

Info

Publication number
NO831390L
NO831390L NO831390A NO831390A NO831390L NO 831390 L NO831390 L NO 831390L NO 831390 A NO831390 A NO 831390A NO 831390 A NO831390 A NO 831390A NO 831390 L NO831390 L NO 831390L
Authority
NO
Norway
Prior art keywords
radical
alkyl
hydrogen atom
optionally carrying
halogen atom
Prior art date
Application number
NO831390A
Other languages
English (en)
Other versions
NO156048C (no
NO156048B (no
Inventor
Jean-Pierre Kaplan
Pascal George
Jean-Michel Bernardon
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO831390L publication Critical patent/NO831390L/no
Publication of NO156048B publication Critical patent/NO156048B/no
Publication of NO156048C publication Critical patent/NO156048C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
NO831390A 1982-04-21 1983-04-20 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive imidazopyridinderivater NO156048C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8206841A FR2525602A1 (fr) 1982-04-21 1982-04-21 Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO831390L true NO831390L (no) 1983-10-24
NO156048B NO156048B (no) 1987-04-06
NO156048C NO156048C (no) 1987-07-15

Family

ID=9273216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831390A NO156048C (no) 1982-04-21 1983-04-20 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive imidazopyridinderivater

Country Status (19)

Country Link
US (1) US4492695A (no)
EP (1) EP0092459B1 (no)
JP (1) JPS58189180A (no)
AT (1) ATE23860T1 (no)
AU (1) AU553112B2 (no)
CA (1) CA1254207A (no)
DE (1) DE3367918D1 (no)
DK (1) DK173783A (no)
ES (1) ES521651A0 (no)
FI (1) FI73998C (no)
FR (1) FR2525602A1 (no)
GR (1) GR78577B (no)
HU (1) HU189648B (no)
IE (1) IE54923B1 (no)
IL (1) IL68443A0 (no)
NO (1) NO156048C (no)
NZ (1) NZ203955A (no)
PT (1) PT76574B (no)
ZA (1) ZA832787B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
WO1998025926A1 (en) * 1996-12-11 1998-06-18 Takeda Chemical Industries, Ltd. Imidazopyridine derivatives and their production
AUPP278498A0 (en) 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
DK1219621T3 (da) * 1999-07-30 2004-02-02 Zenyaku Kogyo Kk Azaindolizinonderivater og cerebral funktionsforbedrende midler indeholdende disse som den aktive bestanddel
IT1318624B1 (it) 2000-07-14 2003-08-27 Dinamite Dipharma S P A In For Processo per la preparazione di 2-fenil-imidazo (1,2-a)piridin-3-acetammidi.
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2010117787A2 (en) * 2009-03-30 2010-10-14 The Brigham And Women's Hospital, Inc. Inhibiting eph b-3 kinase
CN110483499A (zh) * 2009-11-05 2019-11-22 圣母大学 咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
CN103360387B (zh) * 2012-03-28 2016-12-14 江苏豪森药业集团有限公司 一种制备化合物唑吡坦的方法
EP3328382A4 (en) 2015-09-17 2018-12-19 Marvin J. Miller Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
WO2017214442A1 (en) 2016-06-08 2017-12-14 President And Fellows Of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
CN107163039A (zh) * 2017-05-11 2017-09-15 浙江工业大学 一种6‑甲基‑2‑对甲苯基咪唑并[1,2‑a]吡啶‑3‑甲醛的制备方法
AU2019279858A1 (en) * 2018-05-29 2020-11-26 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1076089A (en) * 1965-11-09 1967-07-19 Selvi & C Lab Bioterapico New derivatives of imidazo [1,2-a]-pyridine and a process for the manufacture thereof
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
GR78577B (no) 1984-09-27
DE3367918D1 (en) 1987-01-15
EP0092459A3 (en) 1984-02-01
HU189648B (en) 1986-07-28
ES8402298A1 (es) 1984-01-16
DK173783A (da) 1983-10-22
IL68443A0 (en) 1983-07-31
FR2525602A1 (fr) 1983-10-28
AU553112B2 (en) 1986-07-03
NO156048C (no) 1987-07-15
DK173783D0 (da) 1983-04-20
ES521651A0 (es) 1984-01-16
NO156048B (no) 1987-04-06
IE830896L (en) 1983-10-21
EP0092459B1 (fr) 1986-11-26
IE54923B1 (en) 1990-03-28
PT76574B (fr) 1986-02-27
FI73998B (fi) 1987-08-31
NZ203955A (en) 1985-11-08
US4492695A (en) 1985-01-08
AU1370083A (en) 1983-10-27
PT76574A (fr) 1983-05-01
FI831349L (fi) 1983-10-22
FI831349A0 (fi) 1983-04-20
JPH0412270B2 (no) 1992-03-04
JPS58189180A (ja) 1983-11-04
CA1254207A (en) 1989-05-16
FR2525602B1 (no) 1984-06-22
EP0092459A2 (fr) 1983-10-26
ATE23860T1 (de) 1986-12-15
ZA832787B (en) 1983-12-28
FI73998C (fi) 1987-12-10

Similar Documents

Publication Publication Date Title
NO831390L (no) Fremgangsmaate for fremstilling av imidazopyridinderivater
ES8402297A1 (es) Un procedimiento de preparacion de derivados de imidazo-(1,2-)piridina.
ES8207537A1 (es) Procedimiento de preparacion de imidazo (1,2-a)piridinas
NO159794C (no) Analogifremgangsm te ved fremstilling av terapeutisk virksomme 7-substituerte theofyllinderivater.
ATE13885T1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel.
DE3161553D1 (en) Thiazolo(3,2-a)pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
ZA821407B (en) Imidazol(1,2-a)quinoline derivatives
IT1150955B (it) Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
NO811185L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tiazolderivater.